Exact Mass: 524.2569
Exact Mass Matches: 524.2569
Found 245 metabolites which its exact mass value is equals to given mass value 524.2569
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Fedratinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EJ - Janus-associated kinase (jak) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl)-, (S)-
Ser Gln Tyr Lys
Valtrate hydrine B4
Glu Ile Thr Tyr
Glu Ile Tyr Thr
Glu Leu Thr Tyr
Glu Leu Tyr Thr
Glu Thr Ile Tyr
Glu Thr Leu Tyr
Glu Thr Tyr Ile
Glu Thr Tyr Leu
Glu Tyr Ile Thr
Glu Tyr Leu Thr
Glu Tyr Thr Ile
Glu Tyr Thr Leu
Phe Pro Val Tyr
Phe Pro Tyr Val
Phe Val Pro Tyr
Phe Val Tyr Pro
Phe Tyr Pro Val
Phe Tyr Val Pro
Ile Glu Thr Tyr
Ile Glu Tyr Thr
Ile Met Val Tyr
Ile Met Tyr Val
Ile Thr Glu Tyr
Ile Thr Tyr Glu
Ile Val Met Tyr
Ile Val Tyr Met
Ile Tyr Glu Thr
Ile Tyr Met Val
Ile Tyr Thr Glu
Ile Tyr Val Met
Lys Asn Thr Tyr
Lys Asn Tyr Thr
Lys Gln Ser Tyr
Lys Gln Tyr Ser
Lys Ser Gln Tyr
Lys Ser Tyr Gln
Lys Thr Asn Tyr
Lys Thr Tyr Asn
Lys Tyr Asn Thr
Lys Tyr Gln Ser
Lys Tyr Ser Gln
Lys Tyr Thr Asn
Leu Glu Thr Tyr
Leu Glu Tyr Thr
Leu Met Val Tyr
Leu Met Tyr Val
Leu Thr Glu Tyr
Leu Thr Tyr Glu
Leu Val Met Tyr
Leu Val Tyr Met
Leu Tyr Glu Thr
Leu Tyr Met Val
Leu Tyr Thr Glu
Leu Tyr Val Met
Met Ile Val Tyr
Met Ile Tyr Val
Met Leu Val Tyr
Met Leu Tyr Val
Met Val Ile Tyr
Met Val Leu Tyr
Met Val Tyr Ile
Met Val Tyr Leu
Met Tyr Ile Val
Met Tyr Leu Val
Met Tyr Val Ile
Met Tyr Val Leu
Asn Lys Thr Tyr
Asn Lys Tyr Thr
Asn Thr Lys Tyr
Asn Thr Tyr Lys
Asn Tyr Lys Thr
Asn Tyr Thr Lys
Pro Phe Val Tyr
Pro Phe Tyr Val
Pro Val Phe Tyr
Pro Val Tyr Phe
Pro Tyr Phe Val
Pro Tyr Val Phe
Gln Lys Ser Tyr
Gln Lys Tyr Ser
Gln Ser Lys Tyr
Gln Ser Tyr Lys
Gln Tyr Lys Ser
Gln Tyr Ser Lys
Ser Lys Gln Tyr
Ser Lys Tyr Gln
Ser Gln Lys Tyr
Ser Tyr Lys Gln
Ser Tyr Gln Lys
Thr Glu Ile Tyr
Thr Glu Leu Tyr
Thr Glu Tyr Ile
Thr Glu Tyr Leu
Thr Ile Glu Tyr
Thr Ile Tyr Glu
Thr Lys Asn Tyr
Thr Lys Tyr Asn
Thr Leu Glu Tyr
Thr Leu Tyr Glu
Thr Asn Lys Tyr
Thr Asn Tyr Lys
Thr Tyr Glu Ile
Thr Tyr Glu Leu
Thr Tyr Ile Glu
Thr Tyr Lys Asn
Thr Tyr Leu Glu
Thr Tyr Asn Lys
Val Phe Pro Tyr
Val Phe Tyr Pro
Val Ile Met Tyr
Val Ile Tyr Met
Val Leu Met Tyr
Val Leu Tyr Met
Val Met Ile Tyr
Val Met Leu Tyr
Val Met Tyr Ile
Val Met Tyr Leu
Val Pro Phe Tyr
Val Pro Tyr Phe
Val Tyr Phe Pro
Val Tyr Ile Met
Val Tyr Leu Met
Val Tyr Met Ile
Val Tyr Met Leu
Val Tyr Pro Phe
Tyr Glu Ile Thr
Tyr Glu Leu Thr
Tyr Glu Thr Ile
Tyr Glu Thr Leu
Tyr Phe Pro Val
Tyr Phe Val Pro
Tyr Ile Glu Thr
Tyr Ile Met Val
Tyr Ile Thr Glu
Tyr Ile Val Met
Tyr Lys Asn Thr
Tyr Lys Gln Ser
Tyr Lys Ser Gln
Tyr Lys Thr Asn
Tyr Leu Glu Thr
Tyr Leu Met Val
Tyr Leu Thr Glu
Tyr Leu Val Met
Tyr Met Ile Val
Tyr Met Leu Val
Tyr Met Val Ile
Tyr Met Val Leu
Tyr Asn Lys Thr
Tyr Asn Thr Lys
Tyr Pro Phe Val
Tyr Pro Val Phe
Tyr Gln Lys Ser
Tyr Gln Ser Lys
Tyr Ser Lys Gln
Tyr Ser Gln Lys
Tyr Thr Glu Ile
Tyr Thr Glu Leu
Tyr Thr Ile Glu
Tyr Thr Lys Asn
Tyr Thr Leu Glu
Tyr Thr Asn Lys
Tyr Val Phe Pro
Tyr Val Ile Met
Tyr Val Leu Met
Tyr Val Met Ile
Tyr Val Met Leu
Tyr Val Pro Phe
8-(2,3-dihydro-1H-inden-5-yl)-N-methoxy-2-(4-(1-methylpiperidin-4-yl)phenylamino)-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide
2,5-bis(2-ethylhexyl)-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione
2-(methylthio)-4,6-bis(N-tert-butyloxy-carbonyl-piperidin-4-yloxy)pyrimidine
L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl)-, (S)-
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Guanadrel sulfate
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Fedratinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EJ - Janus-associated kinase (jak) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
(1R)-2-(cyclopropylmethyl)-N-(2,4-difluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
3-cyclohexyl-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-9-(methanesulfonamido)-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
3-cyclohexyl-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-9-(methanesulfonamido)-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
3-cyclohexyl-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-9-(methanesulfonamido)-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
(1-acetyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
(1s,2s,3r,4ar,5r,6s,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[(2s)-hexahydrofuro[2,3-b]furan-2-yl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl propanoate
(1r,4ar,5s,6r,7s,8r,8ar)-5-[(1s)-1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-6,8-dihydroxy-8a-(hydroxymethyl)-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-7-yl (2s)-2-methylbutanoate
(3s,4e,7s,8r,9e,12r)-12-[(2z)-but-2-en-2-yl]-8-{[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,9-dimethyl-2,6-dioxo-1-oxacyclododeca-4,9-dien-7-yl 3-methylbutanoate
(3e,5s,8r,9r,10s,11r,13r,15r,16s,18z)-11-ethenyl-2,9,20,24,27-pentahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione
12-(but-2-en-2-yl)-8-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,9-dimethyl-2,6-dioxo-1-oxacyclododeca-4,9-dien-7-yl 3-methylbutanoate
14,15-dihydro-15β-methoxy-3-epicaryoptin
{"Ingredient_id": "HBIN001318","Ingredient_name": "14,15-dihydro-15\u03b2-methoxy-3-epicaryoptin","Alias": "NA","Ingredient_formula": "C27H40O10","Ingredient_Smile": "CC1CC(C2(C(C1(C)C3CC4CC(OC4O3)OC)CCC(C25CO5)OC(=O)C)COC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5669","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}